K092291 is an FDA 510(k) clearance for the SKINTACT AND VARIOUS OTHER TRADENAMES. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.
Submitted by Leonhard Lang GmbH (Stillwater, US). The FDA issued a Cleared decision on August 21, 2009 after a review of 23 days - a notably fast clearance cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.